FindTrial
Sign In

Impact of geriatric assessment tools on 1- year mortality in non-metastatic breast cancer patients 65 years and older

PROspecTive Study on the use of gEriatriC assessment Tools for validation of 1- year mortality in non-metastatic breast cancer patients 65 years and older - PROTECT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034792
Enrollment
300
Registered
2021-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

None listed

Sponsors

Tata Memorial Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a study of geriatric breast cancer patients

Exclusion criteria

Exclusion criteria: 1. Not willing to participate 2. Unable to understand the questionnaires

Design outcomes

Primary

MeasureTime frame
Cumulative incidence of 1 year mortality.Timepoint: 1 year—

Secondary

MeasureTime frame
1. Validation of MPI and Onco-MPI for 1-year mortality. 2. Comparison of outcome using MPI and Onco-MPI with conventional prognostic factors. 3. To study quality-of-life using the WHO BREF questionnaire pre- and post-treatment. 4. To study the impact of cancer treatment on the systemic organ functions pre-and post-treatment. 5. Sensitivity of G8 and VES-13 as screening tools for geriatric assessment 6. 2-year mortality Timepoint: 2 year—

Countries

India

Contacts

Public ContactDr Shivani Sable

Tata Memorial Hospital, Mumbai

twadasadawala@actrec.gov.in91-22-24177026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026